{"id":"W4387836897","doi":"10.1016/j.annonc.2023.09.563","title":"386MO Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"AstraZeneca","keywords":"Medicine; Trastuzumab; Oncology; Metastatic breast cancer; Breast cancer; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008152623,0.0008563073,0.001394009,0.0002243864,0.0002689499,0.001018642,0.0005837025,0.0008186778,0.004109857],"category_scores_gemma":[0.0008392068,0.0002463594,0.0008850603,0.0002378379,0.0005519692,0.0006973762,0.000353217,0.00267691,0.0009626156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009050515,"about_ca_system_score_gemma":0.000795233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001291228,"about_ca_topic_score_gemma":0.004337968,"domain_scores_codex":[0.9997533,0.0001136557,0.000006874627,0.00003777102,0.0000183548,0.00007000186],"domain_scores_gemma":[0.9996704,0.0001045543,0.00004686691,0.00002336516,0.00001302432,0.0001419339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8427806,0.009022256,0.003446808,0.0004747388,0.00122135,0.000110343,0.0001459727,0.00221283,0.005553698,0.0003609911,0.004294097,0.1303763],"study_design_scores_gemma":[0.7553111,0.2025485,0.0244793,0.0002285242,0.002159985,0.0003375052,0.0002081876,0.003905258,0.002811185,0.001050918,0.006890902,0.00006868919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98935,0.004094827,0.0001816215,0.0008578787,0.0001510821,0.0002774052,0.0007612774,0.00007067517,0.004255118],"genre_scores_gemma":[0.9879962,0.003372453,0.0006177602,0.0009134145,0.0002253992,0.0004117814,0.001426152,0.00003133803,0.005005492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004109857,"threshold_uncertainty_score":0.01374882,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.215818782700106,"score_gpt":0.5112288047317133,"score_spread":0.2954100220316073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}